文献速递消化道肿瘤与早癌消化内镜

2014至2022年联邦合格健康中心的结直肠癌筛查率:COVID-19后恢复不完全及差异恶化

Colorectal Cancer Screening Rates at Federally Qualified Health Centers From 2014 to 2022: Incomplete Recovery From COVID-19 and Worsening Disparities.
PubMed 文献 · Am J Gastroenterol · 2024-02-05

该研究利用2014至2022年统一数据系统数据,评估联邦合格健康中心(FQHC)的结直肠癌(CRC)筛查率趋势及与近期筛查率变化相关的诊所层面因素。结果显示,全美和加州的筛查率中位数从2014至2019年上升,2020年急剧下降,至2022年仍未恢复至疫情前水平,且恢复程度因FQHC患者特征而异。

要点

  • 全美FQHC的CRC筛查率中位数从2014至2019年上升,2020年急剧下降,至2022年未恢复至疫情前水平。
  • 2019至2020年,服务多数西班牙裔/拉丁裔患者或高比例无家可归患者的FQHC筛查率下降最显著。
  • 2020至2022年,服务多数非西班牙裔黑人患者的FQHC筛查率恢复不成比例。

核心结论

  • 至2022年,FQHC的CRC筛查率未恢复至疫情前水平,且恢复程度因FQHC患者特征而异。
  • 亟需针对FQHC中低且下降的CRC筛查率采取定制干预措施,以减轻日益恶化的CRC差异。

研究设计与样本

  • 利用2014至2022年统一数据系统数据,评估全美、加州和洛杉矶县FQHC的CRC筛查率趋势。
  • 计算每个FQHC从2019至2020年、2020至2021年和2020至2022年的筛查率变化。
  • 使用混合效应线性回归确定与每次筛查率变化相关的诊所层面特征。
  • 共纳入1281家FQHC,2022年有7016181名患者符合CRC筛查条件。

主要发现

  • 在全美和加州,筛查率中位数从2014至2019年上升,2020年严重下降,至2022年未恢复至疫情前水平。
  • 在全美和加州,2019至2020年CRC筛查下降最显著的是服务多数西班牙裔/拉丁裔患者或高比例无家可归患者的FQHC。
  • 2020至2022年,美国FQHC的筛查率未完全恢复,服务多数非西班牙裔黑人患者的FQHC恢复不成比例。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Federally Qualified Health Centers (FQHC) provide preventive health services such as colorectal cancer (CRC) screening to low-income and underinsured individuals. Overall CRC screening participation in the United States declined during the COVID-19 pandemic and recovered by 2021; however, trends in underresourced settings are unknown. METHODS: Using Uniform Data System data from 2014 to 2022, we assessed trends in FQHC CRC screening rates nationally, in California, and in Los Angeles County and determined clinic-level factors associated with recent screening rate changes. For each FQHC, we calculated the screening rate change from 2019 to 2020, 2020 to 2021, and 2020 to 2022. We used mixed-effects linear regression to determine clinic-level characteristics associated with each screening rate change. RESULTS: Across all FQHC (n = 1,281), 7,016,181 patients were eligible for CRC screening in 2022. Across the United States and in California, median screening rates increased from 2014 to 2019, severely declined in 2020, and failed to return to prepandemic levels by 2022. Both nationally and in California, CRC screening declined most dramatically from 2019 to 2020 in FQHC serving majority Hispanic/Latino patients or a high proportion of patients experiencing homelessness. From 2020 to 2022, screening rates did not recover completely in US FQHC, with disproportionate recovery among FQHC serving majority non-Hispanic Black patients. DISCUSSION: CRC screening rates at FQHC did not return to prepandemic levels by 2022, and recovery varied by FQHC patient characteristics. Tailored interventions addressing low and decreasing CRC screening rates in FQHC are urgently needed to mitigate worsening CRC disparities.

来源:Am J Gastroenterol,查看原文。版权归原作者所有。

引用

  1. Zhao MY, Lei YY, Aaronson MRM, et al. Colorectal Cancer Screening Rates at Federally Qualified Health Centers From 2014 to 2022: Incomplete Recovery From COVID-19 and Worsening Disparities. Am J Gastroenterol. 2024. PMID: 38529856. doi:10.14309/ajg.0000000000002706

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。